UCLA Health certified to offer immune cell modification therapy – Daily Bruin
Daily Bruin |
UCLA Health certified to offer immune cell modification therapy
Daily Bruin The Food and Drug Administration approved the treatment, marketed as Yescarta, in October for patients with a type of blood cancer called large-B-cell lymphoma. UCLA is one of about two-dozen medical centers nationwide certified to offer the therapy … |
